Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Sponsor and Collaborators     
Bristol-Myers Squibb

Contact
Usc/Norris Comprehensive Cancer Center     
Los Angeles, California, United States, 90033
Contact: Anthony El-Khoueiry, Site 002            

Texas Oncology     
Dallas, Texas, United States, 75246
Contact: Carlos H. Roberto Becerra, Site 001
            
Scott & White Memorial Hospital And Clinic     
Temple, Texas, United States, 76508
Contact: Lucas Wong, Site 003            

Local Institution     
Edmonton, Alberta, Canada, T6G 1Z2
Contact: Site 005            
Canada, Ontario

Local Institution     
Ottawa, Ontario, Canada, K1H 8L6
Contact: Site 004            

Local Institution     
Villejuif Cedex, France, 94800
Contact: Site 006             

Investigator    
Bristol-Myers Squibb

ClinicalTrials.gov Identifier
NCT01046864